What is the ticker symbol for GH Research?

GH Research trades under the ticker GHRS on NASDAQ.

What sector does GH Research operate in?

GH Research is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GHRS in a portfolio?

PortView shows GHRS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

GH Research (GHRS) Stock Analysis

NASDAQHealthcareBiotechnology

$27.57+0.77%

1-year price historyRange $11.94 – $30.64

52-week range$27.57

$11.83$31.44

What GH Research does

GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.

Key metrics

Market cap

$1.89B

P/E (TTM)

-27.57

EPS (TTM)

$-1.00

Beta

1.29

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$27.96

200-day avg

$19.62

52-week high

$31.44

52-week low

$11.83

CEO

Velichka Valcheva

ETFs linked to GHRS

Broad-market and Healthcare sector ETFs an investor holding GH Research is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GHRS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GHRS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for GH Research?: GH Research trades under the ticker GHRS on NASDAQ.
Which exchange is GHRS listed on?: GHRS is listed on NASDAQ.
What sector does GH Research operate in?: GH Research is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GHRS in a portfolio?: PortView shows GHRS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.